InvestorsHub Logo
Followers 546
Posts 8184
Boards Moderated 3
Alias Born 10/23/2016

Re: None

Friday, 09/18/2020 2:55:26 PM

Friday, September 18, 2020 2:55:26 PM

Post# of 198788
...anyone new: ENZC’s partner in all this, BG-Europe, requested the following from ENZC....which basically opens up their NEW ImmunH anti viral to fight ALL viruses(!!). Some posters have clued into this....here is the meat and bones and proof, and this is before the merge.....after merge like whats been said.....BioClonetics basically is getting 20 years of Clinical Trials for free AND a passed Phase III in HIV wonder drug....ENZC’s ImmunH.

- and now we see why this is such a big deal all the way up to NASDAQ biotech players I am sure… Because they combined this Phase 4 novel new revolutionary HIV drug… With the guys st BioClonetics...… And their ties all around the world in top-tier biotechnology circles… And now we find out about the new CEO is going to the Davos forum… The biggest money forum in the world for medicine!

… so lets connect easy dots to Covid and other viruses… BG Europe requested that ImmunH be registered as an immune modulator....I know this is a longer DD post but if you have time read this… Because ....… Sooner or later… many more Naz and penny Biotech players will also connect the dots...from enzc webpage:



‘Additionally, ImmunoTech BG-Europe has informed Enzolytics that they will be seeking to register the ImmunH product as a ImmuneModulator, allowing use as an adjunct in additional applications to regulate or normalize the Immune System’.


https://enzolytics.com/immunh-bg%2Feurope


So guys this is huge... during the trials they found ImmunH to ALSO KILL other viruses so effectively...that they want to use it for MANY other kinds of ANTI VIRAL uses by NEWLY CLASSIFYING IT as an IMMUN E MODULATOR. So ImmunH can then be tried and used or tried against countless viruses......like im sure Covid 19 too or any other flu. Here is so e Immune Modulator dd:


Given the complex nature of the immune response with COVID-19, there is little surprise that a diverse group of immunomodulators are being evaluated in clinical trials  We highlight many of them here.“


https://cellculturedish.com/covid-19-therapeutics-in-clinical-trials-the-immunomodulators/

...or here’s the NIH recently giving an Immune Modulator the green light to be used for Covid(!):


Immunomodulators Under Evaluation for the Treatment of COVID-19
Last Updated: July 30, 2020

Summary Recommendations
Dexamethasone
On the basis of the preliminary report from the Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial, the Panel recommends using dexamethasone 6 mg per day for up to 10 days for the treatment of COVID-19 in patients who are mechanically ventilated (AI) and in patients who require supplemental oxygen but who are not mechanically ventilated (BI)


https://www.covid19treatmentguidelines.nih.gov/immune-based-therapy/immunomodulators/


Dexamethasone reduces mortality by one-third in ventilated patients with COVID-19”

https://www.healio.com/news/pulmonology/20200616/dexamethasone-reduces-mortality-by-onethird-in-ventilated-patients-with-covid19



..now from Immuntech ENZC’s webpage:


Welcome to Immunotech Laboratories BG,
We are a corporation, which is dedicated to the development of medicine for HIV-1 Infection, Chronic Infection, Hepatitis(A,B,C), Rheumatoid Arthritis, some types of Cancer and every other viruses connected with the immune system of the human being.

We have tested ImmunH on volunteers and the medicine has shown that it is highly effective (for full destruction of the viruses) and is absolutely harmless. ImmunH can also be used to strengthen the immune system in people that are not infected with a virus, because it is a natural product. 

https://www.immunotechlaboratoriesbg.com




So ImmunH is classified as HIV killer after all their clinical trials....and now also an open-ended Immune Modulator as well to go after ALL viruses.......with no side effects too?

Mike drop.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENZC News